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ABSTRACT 
Background: It is widely believed that females have longer telomeres than males, although results 
from studies have been contradictory. 
Methods: We carried out a systematic review and meta-analyses to test the hypothesis that in 
humans, females have longer telomeres than males and that this association becomes stronger with 
increasing age. Searches were conducted in EMBASE and MEDLINE (by November 2009) and 
additional datasets were obtained from study investigators. Eligible observational studies measured 
telomeres for both females and males of any age, had a minimum sample size of 100 and included 
participants not part of a diseased group. We calculated summary estimates using random-effects 
meta-analyses. Heterogeneity between studies was investigated using sub-group analysis and meta-
regression. 
Results: Meta-analyses from 36 cohorts (36,230 participants) showed that on average females had 
longer telomeres than males (standardised difference in telomere length between females and 
males 0.090, 95% CI 0.015, 0.166; age-adjusted). There was little evidence that these associations 
varied by age group (p = 1.00) or cell type (p = 0.29). However, the size of this difference did vary by 
measurement methods, with only Southern blot but neither real-time PCR nor Flow-FISH showing a 
significant difference. This difference was not associated with random measurement error. 
Conclusions: Telomere length is longer in females than males, although this difference was not 
universally found in studies that did not use Southern blot methods. Further research on 
explanations for the methodological differences is required. 
 
1. INTRODUCTION 
Telomeres are nucleoprotein complexes at chromosome ends, where the DNA component is a 
repetitive stretch of (TTAGGG), which caps and protects the end of the chromosome. Some studies 
have found that shorter telomeres are associated with obesity (Nordfjall et al., 2008a), gender 
(Bekaert et al., 2007), lower socioeconomic position (Cherkas et al., 2008), smoking (Valdes et al., 
2005) and mortality (Cawthon et al., 2003). Hence telomere length has been proposed as a useful 
index of biological age (Hunt et al., 2008), although this has been called into question (von Zglinicki, 
2012). The present study focuses on the association with gender. In the literature there are 
inconsistencies in the association between gender and telomere length. Some studies (Nawrot et al., 
2004; Bekaert et al., 2007; Fitzpatrick et al., 2007) have found white blood cell telomeres to be 
longer in women than men. Several hypotheses have been postulated to explain this association 
(Nawrot et al., 2004; Mayer et al., 2006; Barrett and Richardson, 2011). One is the action of 
oestrogen (Mayer et al., 2006). An oestrogen-responsive element is present in telomerase reverse 
transcriptase (hTERT) (Nawrot et al., 2004), hence oestrogen might stimulate telomerase to add 
telomere repeats to the ends of chromosomes. Furthermore, telomeres are particularly sensitive to 
oxidative stress (von Zglinicki, 2002) and women produce fewer reactive oxygen species than men 
(Nawrot et al., 2004). It has been suggested that women might also metabolise reactive oxygen 
species better because of oestrogen (Nawrot et al., 2004), due to its antioxidant properties (Carrero 
et al., 2008). However, other studies have found that it is not always the case that telomere length is 
longer in females than males (Hunt et al., 2008; Shiels et al., 2011) or even the reverse (Adams et al., 
2007). At birth, one study found that there was little difference in telomere length between the 
sexes (Okuda et al., 2002), but another study found that female new-borns had longer telomeres 
than males (Aubert et al., 2012). In another study, (Hunt et al., 2008) no difference was detected in 
the telomere length of women and men in the younger Bogalusa Heart Study cohort (19–37 years), 
but in the older Family Heart Study cohort (30–93 years) telomeres were longer in women than men. 
Hence the association between gender and telomere length might vary by age.Whilst telomere 
length is inversely related to chronological age in humans (Shiels et al., 2011), there are concerns 
about how robust telomere length is as a biomarker of ageing (Shiels, 2010; Shiels et al., 2011). 
Existing studies of the association of gender and telomere length in humans have a number of 
limitations. For example, some of the studies are small e.g. (Benetos et al., 2001) and hence may not 
have sufficient power to detect gender differences in telomere length. Furthermore, here are 
methodological differences between assay methods (Aviv et al., 2006), with Southern Blot providing 
a mean terminal restriction length for DNA fragments containing the telomeric DNA stretch plus sub-
telomeric regions of variable length and sequence composition and real-time PCR measuring actual 
telomere -repeat length relative to a reference gene (Aviv et al., 2006). The most frequent cell types 
used in studies on telomere length are either whole blood (leukocytes made up of lymphocytes, 
monocytes and granulocytes) or peripheral blood mononuclear cells (PBMCs made up of 
lymphocytes and monocytes). In adults, lymphocytes have shorter telomeres than granulocytes (Aviv 
et al., 2006), hence it is important to assess whether the association between gender and telomere 
length varies by cell type.  
 
A literature search and qualitative meta-analysis (Barrett and Richardson, 2011) found that at a 
qualitative level, males tended to have shorter telomeres than females. However, no systematic 
review of the literature has been done to examine the association between gender and telomere 
length. We carried out a systematic review and meta-analyses to test the hypothesis that in human 
populations females have longer telomeres than males and that this association becomes stronger 
with increasing age. Furthermore, we also investigated whether the association between gender and 
telomere length varied by method of measurement of telomere length or cell type. Our study has 
several advantages over the earlier review: (a) our study is a systematic review and meta-analysis; 
(b) has standardised effect estimates; (c) has more rigorous methodology including exploration of 
sources of heterogeneity.  
 
We hypothesised that there would be an association between gender and telomere length, with 
females having longer telomeres than males and that this association would become stronger with 
increasing age. 
 
2. METHODS 
We undertook a systematic review of the published literature following the meta-analysis of 
observational studies in epidemiology (MOOSE) guidelines (Stroup et al., 2000) and the PRISMA 
statement (Moher et al., 2009) and we include a completed PRISMA checklist (Supplementary 
Data 1). Full review protocol is available in Supplementary Data 2.  
 
2.1. Selection criteria 
Eligible observational studies had a minimum number of 100 participants and measures of telomere 
length for both males and females. Participants were those of any age (from new-borns through to 
oldest old) who were community dwelling at time of measurement of telomere length and who 
were not part of a diseased group (including healthy controls from case-control studies). Hence we 
excluded cancer tissue studies with measurements of telomere length and those control participants 
who were recruited from hospital in-patients. 
 
2.2. Literature search and data extraction 
Searches of the electronic databases MEDLINE and EMBASE (up to November 2009) were performed 
using text word search terms and explosion MeSH terms (Supplementary Data 2) by MG. Searches 
were restricted to studies of humans. Fig. 1 shows the identification of published studies. Combining 
the results of the MEDLINE and EMBASE electronic searches and removing duplicate records left 
abstracts of 6822 unique records to be screened by three authors (DB, MG and LW). Each of the 
three authors (DB, MG and LW) were responsible for screening one-third of the titles and abstracts 
of these 6822 papers and any considered to be ‘uncertain’ were independently screened by a second 
author. Sixty-one research papers were retrieved for full data extraction using a standardised data 
extraction form. Two authors (from DB, MG and LW) independently extracted the information and 
data of relevance from each of the 61 papers and any differences between the two sets of 
information extracted were resolved through discussion. The standardised data extraction included 
methods of measurement of telomere length, cell type, details of measurement error, details of 
sample recruitment, descriptive characteristics and unadjusted, age-adjusted and fully-adjusted 
measurements of differences in telomere length between females and males. 
 
2.2.1. Data requested from eligible studies 
We contacted the corresponding authors of the 61 eligible published research papers and asked 
them to complete standardised results tables or provide the data for us to analyse (Supplementary 
Data 3). We requested the regression coefficient representing the age-adjusted difference in 
telomere length between females and males, along with corresponding standard error. We asked 
that the study authors calculate regression coefficients using linear regression with raw telomere 
length as the outcome variable. We also requested that the study authors provide the mean age and 
telomere length (plus standard deviations) of males, females and total sample. After sending out one 
reminder, we received responses from 24 of the published research papers (28 datasets) (Fig. 1). 
Authors of 17 research papers provided standard sets of results and authors of another 7 research 
papers provided datasets for us to analyse. 
 
2.3. Inclusion of other studies 
2.3.1. HALCyon cohort studies 
We included unpublished data from three of the nine UK cohort studies involved in the HALCyon 
collaboration. These were the Hertfordshire Ageing Study (HAS) (Syddall et al., 2010), the Lothian 
Birth Cohort 1921 (LBC1921) (Deary et al., 2004) and the MRC National Survey of Health and 
Development (NSHD) (Kuh et al., 2011). These studies had telomere length data available at two 
time points up to 10 years apart. 
 
2.3.2. Other relevant studies 
We contacted the corresponding author of an additional study identified through the literature 
search (Yamaguchi et al., 2005) which included at the time unpublished reference group telomere 
length data. The corresponding author subsequently provided us with the published reference group 
telomere length data (Aubert et al., 2012) for both granulocytes and lymphocytes. Furthermore, 
following e-mail contact with the corresponding authors of the 61 eligible published research 
papers, the corresponding authors of two unpublished studies: HyperGEN (Mangino et al., 2012) and 
the PREVEND Study (Huzen et al., 2011) contributed datasets (two from the HyperGEN study). An 
additional study (Newcastle 85+ study (Martin-Ruiz et al., 2011)) was identified through the HALCyon 
collaboration (www.halcyon.ac.uk) and a further study (The West of Scotland Twenty-07 
Study (Der et al., 2012)) was identified through the FALCon collaboration 
(www.nshd.mrc.ac.uk/collaborations/falcon.aspx). The West of Scotland Twenty-07 Study 
contributed three datasets. Corresponding authors of the HyperGEN (Mangino et al., 2012), 
PREVEND (Huzen et al., 2011), Newcastle 85+ (Martin-Ruiz et al., 2011) and The West of Scotland 
Twenty-07 (Der et al., 2012) studies provided us with standard sets of results and each of these 
studies are now published. Hence these other relevant studies contributed an additional nine 
datasets from five separate studies. 
 
So in total there are 40 datasets (28 datasets from published searches; 9 datasets from other 
relevant studies and 3 unpublished Halcyon cohort studies) from 32 separate studies. 
 
2.4. Telomere length measures 
Telomere length was measured by terminal restriction fragment (TRF) Southern Blot, real-time PCR 
or Flow-FISH (Aviv et al., 2006) in the eligible studies. Flow-FISH is a cytogenetic technique requiring 
intact cells to quantify the length of telomeres (Aviv et al., 2006). Cell types were whole blood, 
peripheral blood mononuclear cells (PBMC), lymphocytes or granulocytes (Aviv et al., 2006). Whole 
blood (leukocytes) cells were made up of lymphocytes, monocytes and granulocytes. These were 
prepared by red cell lysis and/or centrifugation of whole blood without Ficoll (buffy coat). PBMC 
(lymphocytes and sometimes variable fraction of monocytes) were prepared by whole blood 
centrifugation through a Ficoll cushion or gradient. Lymphocytes or granulocytes were used when 
specific cell fractions were isolated during the Flow-FISH method. 
 
2.5. Statistical methods 
We performed a two stage meta-analysis. Firstly equivalent models were run within each cohort. 
This involved using linear regression models to analyse the association between gender and 
telomere length adjusted for age. We made males the baseline group so that the regression 
coefficient represented the difference in telomere length for females compared to males. Some 
studies measured absolute telomere length in kb and others measured Telomere-to-Single Copy 
Gene (T/S) ratio (Real-time PCR). Furthermore, those laboratories using Real-time PCR methodology 
might use different reference samples (Horn et al., 2010) and also might change their reference 
sample when it runs out. To overcome such differences we standardised the regression coefficients 
(and corresponding standard error) by dividing both regression coefficient and standard error by the 
standard deviation of telomere length. 
 
Secondly, the cohort specific standardised regression coefficients and standard errors were pooled 
using random effects meta-analyses (Der Simonian and Laird, 1986). We ran meta-analyses on 
results from models with age-adjusted as a continuous term and then from models with age-
adjusted in quartiles. We included data from36 datasets (published and unpublished studies) in our 
meta-analyses and included the remaining four datasets in sensitivity analyses. This was because 
two studies (Aubert et al., 2012; Halaschek-Wiener et al., 2008) had data on both granulocytes and 
lymphocytes and two studies (Nordfjall et al., 2008a,b) included the MONICA cohort study which 
was part of the more recent NSHDS cohort study which also included the VIP and MSP cohort studies 
(Nordfjall et al., 2009). Hence we wanted to make sure that the same sample was not included more 
than once within a meta-analysis. Furthermore, the 3 HALCyon studies and another study 
(Nordfjall et al., 2009) had repeat telomere length measures (time 1 and time 2). We thus ran meta-
analyses first including these studies at time 1 and then including these four studies at time 2.We 
investigated between study heterogeneity using I2 and Q statistics (Higgins and 
Thompson, 2002; Higgins et al., 2003).We examined potential sources of heterogeneity for age 
group (above versus below the median age), method of measurement of telomere length and cell 
type by stratifying random effects meta-analyses by each of these factors and by running meta-
regression analyses (Thompson and Sharp, 1999). For meta regression analyses, we used post-
estimation Wald tests to obtain F ratios and p values. To address non-linearity and variation with age 
we undertook a meta-regression of effect size on mean age and tested a quadratic or cubic 
relationship. We used funnel plots to assess publication bias and tested the symmetry of the funnel 
plots using Egger's test (Egger et al., 1997). 
 
We undertook a series of sensitivity analyses: (1) for the studies where we had access to the dataset, 
we repeated the test of association between gender and telomere length using transformed 
telomere length data (loge) and compared this to the results from meta-analysis using raw data for 
telomere length, to address the issue of positive skewness in telomere length measurements; (2) we 
excluded those studies where there was no detail of how the healthy participants were sampled and 
repeated the meta-analyses; (3) we repeated analyses using lymphocyte data rather than 
granulocyte data for two studies (Aubert et al., 2012; Halaschek-Wiener et al., 2008); (4) we replaced 
results from (Nordfjall et al., 2009) with data from either (Nordfjall et al., 2008a) or (Nordfjall et al., 
2008b) to avoid using the same study population in meta-analyses more than once and repeated the 
analyses; (5) we repeated meta-analyses including only those studies who reported intra-assay or 
inter-assay coefficient of variation (CV); (6) we repeated meta-analyses having excluded those 
studies which had telomere length measured by any laboratory which appeared to have outlier 
values. 
 
2.6. Methodological checks 
As the data from the Newcastle group contributed to the apparent heterogeneity, a series of post 
hoc methodological checks was performed by this group. 
 
3. RESULTS 
Forty datasets contributed results to this review. Table 1 presents the characteristics of these 
studies. Three studies (Hunt et al., 2008; Chen et al., 2009; Kaplan et al., 2009) each had telomere 
length data stratified for black and white participants and these data are presented separately. 
Mean age ranged from 36.6 ± 0.4SD years in The West of Scotland Twenty-07 Study to 89.9 ± 3.2SD 
years in the Leiden 85+ Study. The method of measurement of telomere length was TRF Southern 
Blot in 17 datasets, Real-time PCR in 19 datasets and Flow-FISH in four datasets. Telomere lengths 
were measured in whole blood (27 datasets), PBMC (8 datasets), granulocytes (2 datasets) and 
lymphocytes (3 datasets). 
 
3.1. Meta-analyses 
Overall summary estimates of effects for the associations between gender and telomere length are 
detailed in Table 2. Meta-analyses from the 36 cohorts (36,230 participants) showed that gender 
was associated with telomere length, with females having longer telomeres on average than males 
(standardised difference in telomere length between females and males 0.090, 95% CI 0.015, 0.166, 
p = 0.02; age adjusted; Fig. 2). These results included the 3 HALCyon studies and Nordfjall et al., 2009 
at time 1. When these analyses were repeated but including these 4 studies at time 2 rather than 
time 1 (where the difference in mean ages between times 1 and 2 ranged from 7.5 years to 10 
years), the associations between gender and telomere length were present, again showing that 
females had longer telomeres than males (p b 0.001).  
 
3.2. Heterogeneity 
There was evidence of substantial heterogeneity between studies (I2 = 91.4%, 95% CI 89.0, 93.2, p< 
0.001) (Table 2). There was little evidence that the association between gender and telomere length 
varied by age group (F ratio = 0.00, p = 1.00; Table 2; Fig. 3) but did vary by the method of telomere 
length measurement (F ratio = 5.72, p = 0.007; Table 2; Fig. 4). There was moderate heterogeneity 
between studies using the TRF Southern Blot method (I2 = 68.8%, 95% CI 48.5, 81.1, p b 0.001) and 
high heterogeneity between studies using the Real-time PCR method (I2 = 93.2%, 95% CI 90.6, 95.1, 
p < 0.001) and the summary estimates of effect showed longer telomeres in females than males only 
for the TRF Southern Blot method. There was little evidence that the associations between gender 
and telomere length varied by cell type (F ratio = 1.31, p = 0.29; Table 2; Fig. 5). The results in Table 2 
include the 3 HALCyon studies and Nordfjall et al., 2009 at phase 1. When these analyses were 
repeated but including these 4 studies at phase 2, there was again little evidence that the 
associations varied by age group (F ratio = 0.06, p = 0.80) or by cell type (F ratio = 0.99, 
p = 0.41) but there was still evidence (albeit weaker) that the association between gender and 
telomere length varied by method to measure telomere length (F ratio = 3.10, p = 0.06). There was 
little evidence that the association between telomere length and gender had a nonlinear variation 
with age (data not shown). For comparison purposes for the TRF Southern Blot method, the overall 
summary estimates of the absolute difference in telomere length between females and males was 
176 bp (95% CI 131, 221, p b 0.001; age-adjusted). 
 
3.3. Publication bias 
The funnel plots (data not shown) and Egger test (bias = −1.52, p = 0.15) did not show strong 
evidence for small study bias. 
 
3.4. Sensitivity analyses 
We found no evidence that the association between gender and telomere length differed whether 
we used raw data for telomere length, or whether it was transformed (loge) (data not shown). 
Excluding studies where there were no details of how the healthy participants were sampled had 
little effect on the findings. The Egger test using these studies, showed that there was again no 
strong evidence for small study bias (bias = −1.76, p = 0.18; including phase 1 data). Repeating the 
analyses including lymphocyte data rather than granulocyte data for the two studies with both data 
made little difference to the associations (data not shown). Replacing (Nordfjall et al., 2009) study 
with data from either (Nordfjall et al., 2008a) or (Nordfjall et al., 2008b) again had little effect on the 
associations. Eight out of 22 studies reported values for intra-assay CV and 4 out of 22 studies 
reported values for inter-assay CV. Repeating the analyses but including only those 10 studies who 
reported intra-assay or inter-assay CV in their studies, showed that gender was strongly associated 
with telomere length, with females having longer telomeres than males. 
 
4. DISCUSSION 
4.1. Explanation of findings 
The results of these meta-analyses showed that gender was associated with telomere length, with 
females having longer telomeres on average than males, even though significant heterogeneity 
between studies was detected. There was little evidence that the strength of the associations varied 
by age group or by cell type. However, the association between gender and telomere length did vary 
by measurement methods. The summary estimates of effect showed longer telomeres in females 
than males only for the TRF Southern Blot method, but not for the Real-time PCR nor the Flow-FISH 
method. However, there was significant heterogeneity between studies, particularly for the Real-
time PCR method (I2 = 93.2%) but also for TRF Southern Blot (I2 = 68.8%) methodologies. Moreover, 
heterogeneity was also confirmed by more recent large Real-time PCR studies which did (Weischer 
et al., 2012) or did not (Needham et al., 2013) identify shorter telomeres in males than females. 
These results suggest two alternative conclusions: (i) women have longer telomeres than men, and 
the failure of the PCR and Flow-FISH methods to detect this difference reproducibly is related to 
higher experimental variability of these techniques, or (ii) there is no consistent gender difference in 
telomere length but a methodological bias specific to the Southern blot technique. The overall 
outcome of the present systematic review argues in favour of the first conclusion. In addition, a 
number of biological plausible arguments for longer telomeres in women than in men have been 
made. These include the action of oestrogen which can stimulate the production of telomerase and 
might be protective against reactive oxygen species damage (Aviv, 2002) and the heterogametic sex 
hypothesis (Barrett and Richardson, 2011) stating that any deleterious recessive alleles on the X 
chromosome of the heterogametic sex (males in humans (XY)), will have no compensatory allele, 
unlike in females where the second chromosome might compensate (Austad, 2006). Hence, shorter 
telomeres in males might arise if the unguarded X chromosome in males contains inferior telomere 
maintenance alleles (Barrett and Richardson, 2011). It has been suggested that longer telomere 
length in women than men might arise from a slower rate of telomere attrition in women 
(Okuda et al., 2002). In both cross-sectional (Bekaert et al., 2007) and longitudinal studies (Chen et 
al., 2011) the rate of leukocyte telomere length shortening was slower in women than men. 
However, the associations were not strong and hence need to be confirmed in larger studies 
(Chen et al., 2011). In the present study, there was little evidence that the strength of the 
association between gender and telomere length varied by age group (above versus below the 
median age of 55.6 years). It is not clear whether gender dependent differences in telomere length 
are already present at birth: One study found that there was little difference in telomere length 
measured by TRF Southern Blot between the sexes at birth (Okuda et al., 2002), while a recent study 
using Flow-FISH found that female new-borns had longer telomeres than males (Aubert et al., 2012). 
It has been suggested that longer telomeres might be a cause of improved fitness in women, 
manifest in longer lifespan and lower risk for cardiovascular disease and cancers (Aviv, 2002). 
However, the picture might be more complex: While short leukocyte telomere length has been 
associated with cardiovascular risk factors (Benetos et al., 2001; Bekaert et al., 2007; Fitzpatrick et 
al., 2007; Nordfjall et al., 2008b; Shiels et al., 2011) and cardiovascular disease (Brouilette et al., 
2007; Fitzpatrick et al., 2007), it did not predict risk for enhanced cancer incidence in carefully 
controlled prospective studies (Weischer et al., 2013) and for some cancers including breast cancer, 
long rather than short telomeres were associated with increased risk (Pellatt et al., 2013). While 
males die at a higher rate at virtually every age (Austad, 2006), associations of telomere length with 
mortality have shown contradictory results (Cawthon et al., 2003; Bischoff et al., 2006; Fitzpatrick et 
al., 2011). Finally, females show higher incidence and prevalence of many age-related diseases 
(except cardiovascular disease and cancer) and disabilities (Collerton et al., 2009). Many of these 
including, for example, multiple-morbidity (Sanders et al., 2012), rheumatoid arthritis 
(Costenbader et al., 2011) or depression (Puterman et al., 2013) have been associated with short 
telomeres. Together, these data do not suggest a general association between gender-specific 
telomere length and fitness in domains other than cardiovascular disease. 
 
A large part of the heterogeneity of the real-time PCR studies can be attributed to a single group. 
The von Zglinicki group repeatedly reported longer telomeres in men than in women (Deary et al., 
2004; Martin-Ruiz et al., 2005, 2011; Adams et al., 2007; Syddall et al., 2010; Kuh et al., 2011). A post 
hoc analysis excluding these studies (Deary et al., 2004; Martin-Ruiz et al., 2005, 2011; Adams et al., 
2007; Syddall et al., 2010; Kuh et al., 2011) now showed longer telomeres in females than males for 
the Real-time PCR method (standardised difference in telomere length between females and males 
0.134, 95% CI 0.053, 0.215, p = 0.001). However, there was still evidence of moderate heterogeneity 
(e.g. Real-time PCR I2 = 72.9%). To address the possibility of methodological errors, a number of 
methodological checks were performed by the von Zglinicki group. Coding errors were ruled out by 
independent cross-checks. Inter-assay CV were measured repeatedly and always found to be below 
6%. PCR efficiencies were estimated both from standard curves and as single-well efficiency. Plate-
to-plate efficiency variation was below 1% for the reference gene PCR and below 2.7% for telomere 
PCR. The intra-plate single-well efficiency CV was always below 3%. Finally, telomere length of the 
Newcastle 85+ study participants (which showed longer telomeres in men than women PBMCs) was 
repeated using whole blood and a different reference gene with the same result. Interestingly, 
Southern blot telomere length studies in patient cohorts done by the von Zglinicki group showed a 
tendency towards longer telomeres in women in agreement with the Southern blot studies included 
in the present review (von Zglinicki et al., 2000; Martin-Ruiz et al., 2006). Thus, there is no obvious 
methodological explanation for the fact that the Newcastle group found longer telomeres in men in 
most of their analysed cohorts, using Real-time PCR methodology. 
 
Smaller measurement error in the TRF Southern Blot method as compared to the Real-time PCR 
methodology might explain greater consistency of findings between studies using the Southern blot 
technique (Aviv et al., 2011). In a recent blinded study (Aviv et al., 2011), the inter-assay CV was 
much larger (6.45%) for the Real-time PCR method performed by the Blackburn group than that of 
the TRF Southern Blot method as performed by the Aviv group (1.74%). However, this difference is 
probably not representative for the field as a whole. In the literature, inter-assay CV has ranged from 
2.3% to 28% for Real-time PCR methods and from 1.5% to 12% for TRF Southern Blot methods (Aviv 
et al., 2011). In the studies included here, where reported, coefficient of variation ranged from 1.7% 
to 11.1% for Real-time PCR and from 1.4% to 12% for TRF Southern Blot. In a fully blinded 
comparative telomere length assessment involving 10 different groups, many of which also 
contributed data to the present analysis, median inter-assay CVs were not significantly different 
between techniques (p = 0.86, in preparation). Excluding the data with the lowest reported CVs 
generated by the Aviv group had little impact on effect size (0.174, 95% CI 0.045, 0.303, p b 0.01) or 
heterogeneity (I2 = 59.6%, p < 0.03) for the Southern blot results, although the average of the 
reported CVs for the remaining groups using the Southern blot technique was now 7.4%. Therefore, 
differences between Southern blotting and the two other techniques cannot be due to technology-
specific random measurement error. However, our results do not rule out the possibility of 
technology specific bias. Various types of polymorphisms will have technology specific impact on 
telomere length if measured by Southern blot versus PCR or Flow-FISH. The most probable of these 
are polymorphisms affecting the most distal recognition sites for the endonucleases Hinf1 and RSA1 
typically used in TRF Southern blotting. Subtelomeric regions exhibit high levels of sequence 
polymorphism and strong linkage disequilibrium, leading to the existence of relatively few common 
haplotypes (Baird et al., 1995, 2000). The most distal Hinf1/RSA1 recognition site at chromosome 
Xp/Yp, for instance, is polymorphic, resulting in an apparent increase in the length of this telomere if 
measured by Southern blotting in this haplotype (Baird et al., 1995). Interstitial telomere repeats are 
also highly polymorphic due to polymerase template slippage, which can cause either insertion or 
deletion of hexameric repeat units (Mondello et al., 2000). Both short (Ruiz-Herrera et al., 2008) and 
long interstitial telomeric repeats are frequent in the human genome, for instance an interstitial 
repeat at chromosome 22q11 displays length polymorphism ranging from 1 to 4 kb (Samassekou and 
Yan, 2011). Such interstitial sequences will either not contribute to the Southern blot signal at all 
(short interstitial sequences) or register as short telomere. In contrast, they will always increase the 
apparent average telomere length measured by PCR or Flow-FISH. In birds, the amount of interstitial 
telomeric sequence was substantial as compared to the actual telomeres and highly variable 
between species. Most importantly, it was also highly variable between individuals (Foote et al., 
2013). It is not known whether frequencies of any of these polymorphisms might be gender-specific 
in humans. Finally, Hinf1/RSA1 are not fully methylation-insensitive, both may be blocked by 
overlapping CpG methylation. Telomeres tend to be transcriptionally silenced and hyper-
methylated, however, this is a regulated process as evident in the human ICF syndrome, where 
hypomethylation due to lack of the DNA methyltransferase DNMT3b causes abnormally high levels 
of telomere repeat containing RNA (TERRA) and complete failure of telomere maintenance (Deng et 
al., 2010). Subtelomeric hypomethylation in endothelial cells was associated with apparent telomere 
lengthening as measured by Southern blot (Maeda et al., 2013). X inactivation in females might thus 
be expected to skew a subpopulation of telomeres towards apparently larger sizes if measured by 
Southern blot. Whether subtelomeric CpG sites on other chromosomes are differentially methylated 
between the sexes is not known but possible.  
 
4.2. Strengths and limitations 
This large-scale systematic review and meta-analysis examining the association between gender and 
telomere length includes data from 40 datasets. We have followed a strict protocol, testing a priori 
hypotheses, have included several unpublished cohorts, have standardised regression coefficients 
and have undertaken a series of sensitivity analyses. We have thus aimed to minimise a range of 
biases including publication and selection bias. We requested that authors performed their analyses 
in a standard way, so limiting the heterogeneity caused by variation in analysis. Furthermore, 
possible sources of heterogeneity include the differences in the protocols for measuring telomere 
length, which might have biased the associations. We aimed to overcome such differences by 
standardising the regression coefficients and by running sensitivity analyses including raw telomere 
length data and transformed telomere length data (loge). We adjusted for age as a potential 
confounder. Other potential confounders include race, BMI and smoking status (Chen et al., 2011). 
Findings suggest leukocyte telomeres are longer in African Americans than in whites (Hunt et al., 
2008), hence where available (Hunt et al., 2008; Chen et al., 2009; Kaplan et al., 2009) we stratified 
analyses by race. Shorter telomeres have been shown in some studies to be associated with obesity 
(Nordfjall et al., 2008b) and smoking Valdes et al., 2005). Only a small number of studies included 
data on BMI and smoking status and we decided against requesting further adjustments for BMI and 
smoking status as this might lead to inconsistencies in adjustments. In addition to the characteristics 
investigated, it is possible that other factors might vary between studies, for example epigenetic 
status, pro-inflammatory state and pathogen challenge. All these factors interact with each other 
and with telomere length (Aviv et al., 2006; Bekaert et al., 2007; Shiels, 2010; Shiels et al., 2011) and 
could result in heterogeneity. We also undertook several sensitivity analyses- including a control for 
measurement error by only including those studies with intra- or inter-assay CV measures and for 
four studies we included telomere length measures at phases 1 and 2 (up to 10 years apart) and we 
repeated the associations in separate meta-analyses at the two phases. For each of these sensitivity 
analyses, gender was still associated with telomere length, with females having longer telomeres 
than males. We did not assess the quality of the included studies, as quality assessment in meta-
analysis of observational studies is controversial (Stroup et al., 2000). Although this was a large 
systematic review and meta-analysis, we might still have been underpowered for the sub-group 
analyses and meta-regression. Hence whilst the funnel plots and formal tests for publication bias 
gave no strong evidence for publication bias, these still need to be interpreted with caution. Mean 
ages in the study ranged from 36.6 ± 0.4SD years to 89.9 ± 3.2SD years, hence a limitation was that 
there were few studies at younger ages. We adjusted for age as a potential confounder but other 
potential confounders including BMI, smoking status and epigenetic status might have affected the 
strength of the associations. Furthermore, variation in these characteristics between the studies 
might result in heterogeneity. 
 
5. CONCLUSION 
Telomere length was longer on average in females than males and the strength of these associations 
varied by measurement method but not by age group: Southern blot was the only technique 
showing an unequivocal sex difference. This difference cannot be explained by differential random 
measurement error, but might be due to method specific bias. Direct comparison of Southern blot 
results with at least one of the other methods in the same participants would help to clarify whether 
there are real sex differences in telomere length. 
 
Supplementary data to this article can be found online at 
http://dx.doi.org/10.1016/j.exger.2013.12.004. 
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